They were reported to produce IFN-I/IIIs upon intranasal infection with IAV, as assessed by measuring IFN-α/β titers in lung homogenates of mice treated or not treated with an anti-Bst2 antibody [109, 111] or by using IFN-λ reporter mice [113]. The gene discussed is IFNA2; the disease is infection.